IRTC iRhythm Technologies Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IRTC

Price (delayed)

$63.90

Market cap

$1.87B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.2

Enterprise value

$1.86B

Highlights
The revenue has grown by 20% YoY and by 4.1% from the previous quarter
The company's gross profit rose by 15% YoY
IRTC's equity has surged by 148% year-on-year but it is down by 9% since the previous quarter
The quick ratio has soared by 59% YoY but it has contracted by 2.3% from the previous quarter
The company's net income fell by 43% QoQ and by 13% YoY
The EPS has decreased by 39% from the previous quarter and by 2.3% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://www.irhythmtech.com/

Key stats

What are the main financial stats of IRTC
Market
Shares outstanding
29.3M
Market cap
$1.87B
Enterprise value
$1.86B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.02
Price to sales (P/S)
6.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.74
Earnings
Revenue
$275.94M
EBIT
-$60.76M
EBITDA
-$47.29M
Free cash flow
-$47.59M
Per share
EPS
-$2.2
Free cash flow per share
-$1.63
Book value per share
$10.62
Revenue per share
$9.46
TBVPS
$16.38
Balance sheet
Total assets
$478.49M
Total liabilities
$168.92M
Debt
$124.24M
Equity
$309.57M
Working capital
$276.72M
Liquidity
Debt to equity
0.4
Current ratio
5.66
Quick ratio
5.43
Net debt/EBITDA
0.28
Margins
EBITDA margin
-17.1%
Gross margin
71.9%
Net margin
-22.7%
Operating margin
-22.5%
Efficiency
Return on assets
-14.2%
Return on equity
-22.7%
Return on invested capital
-14.9%
Return on capital employed
-14.5%
Return on sales
-22%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IRTC stock price

How has the iRhythm Technologies stock price performed over time
Intraday
0%
1 week
2.92%
1 month
-16.95%
1 year
-44.63%
YTD
-73.06%
QTD
-53.98%

Financial performance

How have iRhythm Technologies's revenue and profit performed over time
Revenue
$275.94M
Gross profit
$198.27M
Operating income
-$61.97M
Net income
-$62.54M
Gross margin
71.9%
Net margin
-22.7%
The company's net income fell by 43% QoQ and by 13% YoY
The operating income has contracted by 42% from the previous quarter and by 11% YoY
The net margin is down by 38% from the previous quarter but it is up by 6% YoY
IRTC's operating margin is down by 36% from the previous quarter but it is up by 7% YoY

Growth

What is iRhythm Technologies's growth rate over time

Valuation

What is iRhythm Technologies stock price valuation
P/E
N/A
P/B
6.02
P/S
6.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.74
The EPS has decreased by 39% from the previous quarter and by 2.3% YoY
IRTC's equity has surged by 148% year-on-year but it is down by 9% since the previous quarter
IRTC's P/B is 71% below its 5-year quarterly average of 20.7 and 70% below its last 4 quarters average of 19.8
The P/S is 66% below the last 4 quarters average of 20.1 and 49% below the 5-year quarterly average of 13.3
The revenue has grown by 20% YoY and by 4.1% from the previous quarter

Efficiency

How efficient is iRhythm Technologies business performance
iRhythm Technologies's ROE has soared by 54% YoY but it has decreased by 19% from the previous quarter
The ROS has decreased by 38% from the previous quarter but it has increased by 6% YoY
IRTC's return on invested capital is down by 35% since the previous quarter but it is up by 9% year-on-year
The ROA has grown by 29% YoY but it has contracted by 27% from the previous quarter

Dividends

What is IRTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IRTC.

Financial health

How did iRhythm Technologies financials performed over time
IRTC's total assets is 183% greater than its total liabilities
IRTC's total assets has surged by 69% year-on-year but it is down by 6% since the previous quarter
The quick ratio has soared by 59% YoY but it has contracted by 2.3% from the previous quarter
The debt is 60% less than the equity
IRTC's equity has surged by 148% year-on-year but it is down by 9% since the previous quarter
The debt to equity has plunged by 61% YoY but it has grown by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.